BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26169986)

  • 1. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jatrophone: a cytotoxic macrocylic diterpene targeting PI3K/AKT/NF-κB pathway, inducing apoptosis and autophagy in resistant breast cancer cells.
    Shari K; El Gedaily RA; Allam RM; Meselhy KM; Khaleel AE; Abdel-Sattar E
    BMC Complement Med Ther; 2023 Aug; 23(1):293. PubMed ID: 37608270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2 silencing promotes cell apoptosis and inhibits drug resistance in chronic lymphocytic leukemia by inhibiting the NF-κB signaling pathway.
    Zheng C; Zhu Z; Weng S; Zhang Q; Fu Y; Cai X; Liu Z; Shi Y
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23510. PubMed ID: 37700718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells.
    Fouad MA; Sayed-Ahmed MM; Huwait EA; Hafez HF; Osman AM
    BMC Pharmacol Toxicol; 2021 Jan; 22(1):8. PubMed ID: 33509300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling.
    Saha A; Blando J; Silver E; Beltran L; Sessler J; DiGiovanni J
    Cancer Prev Res (Phila); 2014 Jun; 7(6):627-38. PubMed ID: 24691500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer.
    Kim SJ; Seo I; Kim MH; Park JW; Kim S; Park WJ
    Lipids Health Dis; 2023 Oct; 22(1):183. PubMed ID: 37885013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.
    Zhou J; Zhang H; Gu P; Bai J; Margolick JB; Zhang Y
    Breast Cancer Res Treat; 2008 Oct; 111(3):419-27. PubMed ID: 17965935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procyanidin B2 3,3(″)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-κB, Stat3, and AP1 transcription factors.
    Tyagi A; Raina K; Shrestha SP; Miller B; Thompson JA; Wempe MF; Agarwal R; Agarwal C
    Nutr Cancer; 2014; 66(4):736-46. PubMed ID: 24191894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway.
    Feng H; Dong Y; Chen K; You Z; Weng J; Liang P; Shi F
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):46. PubMed ID: 38285090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay.
    Vitali E; Valente G; Panzardi A; Laffi A; Zerbi A; Uccella S; Mazziotti G; Lania A
    J Endocrinol Invest; 2024 May; 47(5):1101-1117. PubMed ID: 37882947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polysaccharide from Undaria pinnatifida on proliferation, migration and apoptosis of breast cancer cell MCF7.
    Wu J; Li H; Wang X; Zhang X; Liu W; Wang Y; Zhang Y; Pan H; Wang Q; Han Y
    Int J Biol Macromol; 2019 Jan; 121():734-742. PubMed ID: 30342943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endonuclease FEN1 mediates activation of STAT3 and facilitates proliferation and metastasis in breast cancer.
    Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
    Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin.
    Song Z; Wang Y; Li C; Zhang D; Wang X
    PLoS One; 2015; 10(5):e0127599. PubMed ID: 25993398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors.
    Gabriele E; Brambilla D; Ricci C; Regazzoni L; Taguchi K; Ferri N; Asai A; Sparatore A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1012-1028. PubMed ID: 28738705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Glucose-reduced Apoptosis in Human Breast Cancer Cells Is Mediated by Activation of NF-κB.
    Nasir Kansestani A; Mansouri K; Hemmati S; Zare ME; Moatafaei A
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):153-162. PubMed ID: 31066251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
    Tanaka I; Chakraborty A; Saulnier O; Benoit-Pilven C; Vacher S; Labiod D; Lam EWF; Bièche I; Delattre O; Pouzoulet F; Auboeuf D; Vagner S; Dutertre M
    Nucleic Acids Res; 2020 Mar; 48(5):2676-2693. PubMed ID: 31943118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moringin, an isothiocyanate modulates multiple cellular signalling molecules in breast cancer cells.
    Srivastava A; Mishra S; Avadhesh ; Shekher A; Rai V; Dhasmana A; Das J; Perenzoni D; Iori R; Gupta SC
    Cell Signal; 2024 Jul; 119():111181. PubMed ID: 38643946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling.
    Kubatka P; Koklesova L; Mazurakova A; Brockmueller A; Büsselberg D; Kello M; Shakibaei M
    Cancer Metastasis Rev; 2024 Mar; 43(1):87-113. PubMed ID: 37789138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing or eliminating signals for cell survival to treat disease.
    Tweardy DJ; Jing N
    Trans Am Clin Climatol Assoc; 2006; 117():33-51; discussion 51-2. PubMed ID: 18528463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer.
    Ding L; Jiang H; Li Q; Li Q; Zhang TT; Shang L; Xie B; Zhu Y; Ding K; Shi X; Zhu T; Zhu Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):90. PubMed ID: 38523299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.